Data di Pubblicazione:
2021
Abstract:
COVID-19, a disease caused by SARS-CoV-2 infection, has become a global pandemic. Patients with myasthenia gravis (MG), often treated with immunosuppressants, might be at higher risk of developing COVID-19 and of demonstrating a severe disease course. We aimed to study prevalence and describe features of COVID-19 in MG patients.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
COVID-19; comorbidities; corticosteroids; epidemiology; immunosuppressive treatments; myasthenia gravis
Elenco autori:
Businaro, Pietro; Vaghi, Gloria; Marchioni, Enrico; Diamanti, Luca; Arceri, Sebastiano; Bini, Paola; Colombo, Elena; Cosentino, Giuseppe; Alfonsi, Enrico; Costa, Alfredo; Ravaglia, Sabrina; Mallucci, Giulia; Ballante, Elena; Franciotta, Diego; Gastaldi, Matteo
Link alla scheda completa:
Pubblicato in: